Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142419 |
| CAS No | NA |
| Mol.F. | C14H15N3O |
| Mol.Wt. | 241.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142420 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142421 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 : C2H2O4 |
| Mol.Wt. | 270.3 : 90.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142422 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142423 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142424 |
| CAS No | NA |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142425 |
| CAS No | NA |
| Mol.F. | C27H33N3O3 |
| Mol.Wt. | 447.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142426 |
| CAS No | NA |
| Mol.F. | C27H32N4O4 |
| Mol.Wt. | 476.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142427 |
| CAS No | NA |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142428 |
| CAS No | NA |
| Mol.F. | C8H13ClN6O |
| Mol.Wt. | 244.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142429 |
| CAS No | NA |
| Mol.F. | C8H12ClN7O2 |
| Mol.Wt. | 273.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142430 |
| CAS No | NA |
| Mol.F. | C7H11ClN6O |
| Mol.Wt. | 230.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142431 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142432 |
| CAS No | NA |
| Mol.F. | C25H36N2O5 |
| Mol.Wt. | 444.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142433 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.26 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142434 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 |
| Mol.Wt. | 270.33 g/mol |
| INV STATUS | In Stock |